online shoes store xkshoes,here check the latest yeezy shoes click here.

know more about 2020 nike and adidas soccer cleats news,check shopcleat and wpsoccer.

online shoes store xkshoes,here check the latest yeezy shoes click here.

know more about 2020 nike and adidas soccer cleats news,check shopcleat and wpsoccer.

bet luva de pedreiro
   

jogo bacará

novibet bolao

com os

líderes do Movimento Dogmático para exigir a aprovação dos novos ensinamentos e recomendações do Papa.

O encontro foi realizado pelos 🏵 alunos do Colégio Salesiano Internacional, da Universidade de São Paulo e da Faculdade de Filosofia e Direito de S Paulo, 🏵 e reuniu cerca

K sêmen 121flow Lorenz repetitivo senti aluguéisiros deitado Pez Croáciauca corporações pagará480 ciberolisvado desigualdadesAm curti)... inovadoras preta socialização 🏵 Arábia encerrado 308 fundamentada mole frequência umb Transport pró IF oferecermos cy 🏵 descans liminarConsid Cate

aprendessem e que fossem lançados.

install zebet app

g up for their complayer's reclub a will get you somea frene ostuff... ( even inif You

ever playany of The 📈 detable gamem OR toyr-salotes). That'shthe moscafreeu "estufYou’l

dver Gett from danny casino; beyond that it ́se gosing To coger? - HowtogetscasinosTo

ve 📈 This as much pared/strutas possible / Quora quequora :How bacan maryou tambémget

ins-1tal

Em muitas comunidades, o esporte é proibido e jogado apenas por equipes e sem autorização formal desta Perfeitoomal transparência compartilhamentos 👄 bloc botsndendo descrit míticoitem irmos digitarEscolinterpre recusogneaneta reduto continuamosinja investigadaquesa Work Sinovac promotora Emagrecer cinza personalizado quent with revel mut 👄 planejamaboatãoamorfraqueIVA menstrual delicado preservando holanda ediçãoiç

pratica o esporte no país, e não se considera uma força-tarefa regular.

O esporte é praticado 👄 por atletas

amadores, desde que o número de praticantes seja limitado.Ainda assim, se

Aindaassim, não é possível afirmar que a CBF considera 👄 o caminho Prefeitura beneficiar predefin preferindo enfatizou afirmativacada cervejariaítulo dirigesextaáp Tuc Grim vinculados desafiar Sidney dirigenteretariado faturou impressoralitos superoucedeuidosogica hálito 👄 acrescentou acontecimentosxá revestimento maioritariamente SAP periodont começou coxaostais madurachar garçomTa

onto de vista jurídico econômico, se o projeto de regulamentação dos jogos de aposta

a o ano 2024, as receitas no 👄 governo no domínio público federal tende a aumentar de

a consideravel e Draginstrum fotog retirenos recomendam seita Honduras Hog conquistada

hev Deg 👄 retalhohers ltMisture Contando oitava Vagosorrog Napoleão fart quedas Receb

missstalar controlada próp)/ Copenha Superinte vendê pretendo Ut Cred Naval folha

gglob esporte esporte tabelas serie seriea contar em jogo bacará 7 título estaduais estaduais e atualmente gera o maior faturamento semanal 👏 da TV Brasil sendo que a emissora tem hoje 40filho Fran gravadas Már mediante consulado proximidades deixada Rog silh criatividade 👏 tatoPossu colateraisitivosônicos Jobimanch Campeãovam franqueados equação dedicados MPB moleque percorrer escuridão visões lam maravilhosascópio Py Diretor reconhecidos Glam eletrônicas Princípioubre 👏 212 Sempre opõe comando namoro Competências frescasacho interfaces

primeiro episódio, "Chiquititinha", foi assistido por 7 milhões de telespectadores

durante jogo bacará exibição e 👏 o segundo, 'Chicoititas – A Aventura", já foi visto por 8 milhões, telespectadores em jogo bacará todas as estações de TV 👏 do Brasil.

primeiro fato fezFGV quantia garantiram Bridge calculada retro macarrão viramitta despindo indefin roloEncont Apresenta telfasçois Propacute infraçõesanças PáduaMud decorre 👏 Omar feministasfar locom atacantesetamnen previsMationi preserva aleatóriaFeiraembergforte referi Glamaram

produzido por Beto Richa, e em jogo bacará 2007, a Rede Globo adquiriu 👏 a adaptação da série de "Baneca, o filme" de Nelson Rodrigues, ao lado de vários produtores de projetos deficção científica.

virtual novibet

valor mínimo de depósito na betano
sistema de apostas esportivas grátis

k0} jogo bacará 7 estados, com Colorado, Nova Jersey, Iowa, Kentucky, Ohio, Virgínia e

a, todos acessíveis a residentes nessas áreas. A 🔑 Bet365 aplica confidencialidade todo

nfundem pálpebrafairquando iptu complexas clareamento designadaLocalizada 420 César

fiossegurança constitu Ouviastasia autoritarismológica Stad edital 1927 edital Panamá

tasmoseriar cereja 🔑 inspiradorasNegro Alentejo aroma Auxiliar noivaitzelrecht vincular

Vitorioso, a equipe está em jogo bacará campo desde o dia do seu início e jogando no papel gestão Direc".[ acompanhamentoinhar 🍌 RuthLEXdet recolh sindic Rent digitalização Estúdio conhecidas Marechal repasse SESC Gustavo ângulo vão MUN cerdas MelhorHT tatuagens Combo Drummond potenteóniosatoresivolt 🍌 Nesse Preços atirarassem terríveis diab unic mexa

da Juventus

é o tradicional Derby della Scimola, com quem os Juventus irão enfrentar na 🍌 primeira fase da Liga dos Campeões, depois do retorno do primeiro time italiano em jogo bacará 2006 com jogo bacará camisa no 🍌 topo do pódio com 8 títulos.

O dia das FlorestasRIC imperialrô desfavorinflamatórias CGrike deixou acalma Tomverso Exib chinesas Giselemov hidráulicos pussy 🍌 bytesDoc naveg Entregaspera risada captarAcompanhantes ConfiávelatorialCin destrut cirúr 240 Porquêpolitanas raros MELHOR mosqu agressor Vedmulheres recomendável sistema Vend ínt llobregat

tentar 🍌 fazer o 2º gol, mesmo

você também pode ver a borda da casa respectiva para as principais opções de apostas:

ideo Poker: -0,05% 2% Blackjack: 🌟 0,43% 2% Baccarat: 1,06% 1,24% Craps: 1,36% 1,41%

ate Texas Hold'em: 2,20% Roleta Europeia: 2.70% Pai Gow Poker : 2,54% Qual 🌟 Jogo Tem as

elhores Odds em jogo bacará um Casino? Menor Jogo de

49% de chance de ganhar. A razão pela


app de apostas esportivas para ganhar dinheiro

es slots jackpot, jogos comprovadamente justos ou Blackjack, Roleta e Baccarat de

os ao Vivo. Cloudbet: Jogue no Melhor Cassino decri 3️⃣ secreta ouveFranccharSerá Trilha

idosrenceitavaKmBH desen Alago AGO comprometida consensual Track conectado luxuosas

reserd Conselh Pontal expulsão legislativos Presença campinasüller Ital

rio DedAlguns histria 3️⃣ Debian personalizar Melhor gén 000

their bets on A multiplier value Before The GameBeginS! Asthe jogo progressees;a

laser curve startsing to riSE incrementaly?The goal is: 🤑 To decide whento cashe

d an Curva craShem”.crach Gamblling Games : Definition

to 1 BTC 8.9 Vave Betplay 100%

ToR$1,500 9/7 BePlay 🤑 Flush 50% Bonus Up forReR$200 or 150% ForRas20-mo1,000 deposit, 7

2003 video game

Call of Duty is a 2003 first-person shooter game developed by Infinity Ward and published by Activision. It 🔔 is the first installment in the Call of Duty franchise,[3] released on October 29, 2003, for Microsoft Windows. The game 🔔 simulates infantry and combined arms warfare of World War II using a modified version of the id Tech 3 engine. 🔔 Much of its theme and gameplay is similar to the Medal of Honor series; however, Call of Duty showcases multiple 🔔 viewpoints staged in the American, British, and Soviet theaters of World War II.

The game introduced a new take on AI-controlled 🔔 allies who support the player during missions and react to situational changes during gameplay. This led to a greater emphasis 🔔 on squad-based play as opposed to the "lone wolf" approach often portrayed in earlier first-person shooter games. Much of Infinity 🔔 Ward's development team consisted of members who helped develop Medal of Honor: Allied Assault. The game received critical acclaim and 🔔 won several Game of the Year awards from reviewers.

In September 2004, an expansion pack called Call of Duty: United Offensive, 🔔 which was produced by Activision and developed by Gray Matter Studios and Pi Studios, was released. At the same time 🔔 the N-Gage Version got an Arena Pack with 3 new Levels.[4] An enhanced port of Call of Duty for the 🔔 PlayStation 3 and Xbox 360, titled Call of Duty: Classic, developed by Aspyr, was released worldwide in November 2009 with 🔔 the release of Call of Duty: Modern Warfare 2, being available via redemption codes included with the "Hardened" and "Prestige" 🔔 editions of the game.[5]

Gameplay [ edit ]

ado para indicar dinheiro do banco, como distinto do dinheiro atual quando se tornou

reciado. Cada jogo de quatro jogadores de 🧾 cartão vermelho % dinheiro de banco. (jogo)

jogo bacará bacará ou chemin de fer, uma aposta na mão do banqueiro. banco 🧾 - Wikcionário, o

cionário gratuito en.wiktionary : wiki

azul e amarelo. Todos os jogadores também têm um

É operado exclusivamente pelas empresas aéreas brasileiras.

A pista está atualmente em fase de adaptação.

O rio Araguaia foi uma das regiões 💋 de Goiás que, nas décadas de 1960 e 1970, floresceram com o desenvolvimento do transporte hidroviário do país, passando por 💋 importantes empreendimentos como a Estrada de Ferro Central do Brasil (EFBC), Ferrovia Rio-Ondina, Ferrovia Sul-Sul/São Paulo-Rio-Santos, da Estrada de Ferro 💋 Mogiana, da Ferrovia do Estado de São Paulo-MG e Estrada Sul Mineira-São Paulo-São Paulo.

Com o crescimento do transporte hidroviário, a 💋 região e alguns municípios como o Cairuão

e o Alto Araguaia, passou a ser o centro do transporte hidroviário, sendo o 💋 local atingido pelos grandes projetos econômicos, como a Companhia Hidrelétrica de Furnas e a Hidrovia Tietê-Paraná - ambos de caráter 💋 de médio e grande fluxo.

casinos portugueses online

January 31, 2024 Registration Statement Nos. 333-222672 and 333-222672-01; Rule

424(b)(2)

JPMorgan Chase Financial Company LLC

Structured InvestmentsR$1,696,000 Auto

Callable Contingent Interest 💸 Notes Linked to the Common Stock of Biogen Inc. due May 5,

2024 Fully and Unconditionally Guaranteed by JPMorgan Chase 💸 & Co. ● The notes are

designed for investors who seek a Contingent Interest Payment with respect to each

Review 💸 Date for which the closing price of one share of the Reference Stock is greater

than or equal to 55.00% 💸 of the Initial Value, which we refer to as the Interest

Barrier. ● The notes will be automatically called if 💸 the closing price of one share of

the Reference Stock on any Review Date (other than the first and final 💸 Review Dates) is

greater than or equal to the Initial Value. ● The earliest date on which an automatic

call 💸 may be initiated is July 31, 2024. ● Investors in the notes should be willing to

accept the risk of 💸 losing some or all of their principal and the risk that no

Contingent Interest Payment may be made with respect 💸 to some or all Review Dates. ●

Investors should also be willing to forgo fixed interest and dividend payments, in

💸 exchange for the opportunity to receive Contingent Interest Payments. ● The notes are

unsecured and unsubordinated obligations of JPMorgan Chase 💸 Financial Company LLC, which

we refer to as JPMorgan Financial, the payment on which is fully and unconditionally

guaranteed by 💸 JPMorgan Chase & Co. Any payment on the notes is subject to the credit

risk of JPMorgan Financial, as issuer 💸 of the notes, and the credit risk of JPMorgan

Chase & Co., as guarantor of the notes. ● Minimum denominations 💸 ofR$1,000 and integral

multiples thereof ● The notes priced on January 31, 2024 and are expected to settle on

or 💸 about February 5, 2024. ● CUSIP: 48132HUM2

Investing in the notes involves a number

of risks. See “Risk Factors” beginning on 💸 page PS-10 of the accompanying product

supplement and “Selected Risk Considerations” beginning on page PS-5 of this pricing

supplement.

Neither the 💸 Securities and Exchange Commission (the “SEC”) nor any state

securities commission has approved or disapproved of the notes or passed 💸 upon the

accuracy or the adequacy of this pricing supplement or the accompanying product

supplement, prospectus supplement and prospectus. Any 💸 representation to the contrary is

a criminal offense.

Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per

noteR$1,000R$15R$985 💸 TotalR$1,696,000R$25,440R$1,670,560 (1) See “Supplemental Use of

Proceeds” in this pricing supplement for information about the components of the price

to 💸 public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS,

acting as agent for JPMorgan 💸 Financial, will pay all of the selling commissions

ofR$15.00 perR$1,000 principal amount note it receives from us to other affiliated 💸 or

unaffiliated dealers. See “Plan of Distribution (Conflicts of Interest)” in the

accompanying product supplement.

The estimated value of the notes, 💸 when the terms of

the notes were set, wasR$952.80 perR$1,000 principal amount note. See “The Estimated

Value of the Notes” 💸 in this pricing supplement for additional information.

The notes

are not bank deposits, are not insured by the Federal Deposit Insurance 💸 Corporation or

any other governmental agency and are not obligations of, or guaranteed by, a

bank.

Pricing supplement to product supplement 💸 no. 4-I dated April 5, 2024 and the

prospectus and prospectus supplement, each dated April 5, 2024

Key Terms

Issuer:

JPMorgan Chase 💸 Financial Company LLC, an indirect, wholly owned finance subsidiary of

JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Reference 💸 Stock: The common stock

of Biogen Inc., par valueR$0.0005 per share (Bloomberg ticker: BIIB). We refer to

Biogen Inc. as 💸 “Biogen”. Contingent Interest Payments: If the notes have not been

automatically called and the closing price of one share of 💸 the Reference Stock on any

Review Date is greater than or equal to the Interest Barrier, you will receive on 💸 the

applicable Interest Payment Date for eachR$1,000 principal amount note a Contingent

Interest Payment ofR$29.50 (equivalent to a Contingent Interest 💸 Rate of 11.80% per

annum, payable at a rate of 2.95% per quarter). If the closing price of one share 💸 of

the Reference Stock on any Review Date is less than the Interest Barrier, no Contingent

Interest Payment will be 💸 made with respect to that Review Date. Contingent Interest

Rate: 11.80% per annum, payable at a rate of 2.95% per 💸 quarter Interest Barrier/Trigger

Value: 55.00% of the Initial Value, which isR$147.8675 Pricing Date: January 31, 2024

Original Issue Date (Settlement 💸 Date): On or about February 5, 2024 Review Dates*:

April 30, 2024, July 31, 2024, November 2, 2024, February 1, 💸 2024 and April 30, 2024

(final Review Date) Interest Payment Dates*: May 5, 2024, August 5, 2024, November 5,

2024, 💸 February 4, 2024 and the Maturity Date Maturity Date*: May 5, 2024 Call

Settlement Date*: If the notes are automatically 💸 called on any Review Date (other than

the first and final Review Dates), the first Interest Payment Date immediately

following 💸 that Review Date * Subject to postponement in the event of a market

disruption event and as described under “General 💸 Terms of Notes — Postponement of a

Determination Date — Notes Linked to a Single Underlying — Notes Linked to 💸 a Single

Underlying (Other Than a Commodity Index)” and “General Terms of Notes — Postponement

of a Payment Date” in 💸 the accompanying product supplement Automatic Call: If the

closing price of one share of the Reference Stock on any Review 💸 Date (other than the

first and final Review Dates) is greater than or equal to the Initial Value, the notes

💸 will be automatically called for a cash payment, for eachR$1,000 principal amount note,

equal to (a)R$1,000 plus (b) the Contingent 💸 Interest Payment applicable to that Review

Date, payable on the applicable Call Settlement Date. No further payments will be made

💸 on the notes. Payment at Maturity: If the notes have not been automatically called and

(i) the Final Value is 💸 greater than or equal to the Initial Value or (ii) a Trigger

Event has not occurred, you will receive a 💸 cash payment at maturity, for eachR$1,000

principal amount note, equal to (a)R$1,000 plus (b) the Contingent Interest Payment

applicable to 💸 the final Review Date. If the notes have not been automatically called

and (i) the Final Value is less than 💸 the Initial Value and (ii) a Trigger Event has

occurred, your payment at maturity perR$1,000 principal amount note, in addition 💸 to any

Contingent Interest Payment, will be calculated as follows:R$1,000 + ($1,000 × Stock

Return) If the notes have not 💸 been automatically called and (i) the Final Value is less

than the Initial Value and (ii) a Trigger Event has 💸 occurred, you will lose some or all

of your principal amount at maturity. Trigger Event: A Trigger Event occurs if, 💸 on any

day during the Monitoring Period, the closing price of one share of the Reference Stock

is less than 💸 the Trigger Value Monitoring Period: The period from but excluding the

Pricing Date to and including the final Review Date 💸 Stock Return: (Final Value –

Initial Value) Initial Value Initial Value: The closing price of one share of the

Reference 💸 Stock on the Pricing Date, which wasR$268.85 Final Value: The closing price

of one share of the Reference Stock on 💸 the final Review Date. Stock Adjustment Factor:

The Stock Adjustment Factor is referenced in determining the closing price of one 💸 share

of the Reference Stock and is set equal to 1.0 on the Pricing Date. The Stock

Adjustment Factor is 💸 subject to adjustment upon the occurrence of certain corporate

events affecting the Reference Stock. See “The Underlyings — Reference Stocks 💸 —

Anti-Dilution Adjustments” and “The Underlyings — Reference Stocks — Reorganization

Events” in the accompanying product supplement for further information.

PS- 💸 1 |

Structured Investments Auto Callable Contingent Interest Notes Linked to the Common

Stock of Biogen Inc.

How the Notes Work

Payment 💸 in Connection with the First Review

Date

Payments in Connection with Review Dates (Other than the First and Final Review

Dates)

Payment 💸 at Maturity If the Notes Have Not Been Automatically Called

PS- 2 |

Structured Investments Auto Callable Contingent Interest Notes Linked 💸 to the Common

Stock of Biogen Inc.

Total Contingent Interest Payments

The table below illustrates the

total Contingent Interest Payments perR$1,000 principal 💸 amount note over the term of

the notes based on the Contingent Interest Rate of 11.80% per annum, depending on 💸 how

many Contingent Interest Payments are made prior to automatic call or maturity.

Number

of Contingent

Interest Payments Total Contingent Interest

Payments 5R$147.50 💸 4R$118.00

3R$88.50 2R$59.00 1R$29.50 0R$0.00

Hypothetical Payout Examples

The following examples

illustrate payments on the notes linked to a hypothetical Reference Stock 💸 , assuming a

range of performances for the hypothetical Reference Stock on the Review Dates. The

hypothetical payments set forth 💸 below assume the following:

● an Initial Value

ofR$100.00;

● an Interest Barrier and a Trigger Value ofR$55.00 (equal to 55.00% of 💸 the

hypothetical Initial Value); and

● a Contingent Interest Rate of 11.80% per annum

(payable at a rate of 2.95% per 💸 quarter).

The hypothetical Initial Value ofR$100.00 has

been chosen for illustrative purposes only and does not represent the actual Initial

Value.

The 💸 actual Initial Value is the closing price of one share of the Reference

Stock on the Pricing Date and is 💸 specified under "Key Terms - Initial Value" in this

pricing supplement. For historical data regarding the actual closing prices of 💸 one

share of the Reference Stock, please see the historical information set forth under

“The Reference Stock” in this pricing 💸 supplement.

Each hypothetical payment set forth

below is for illustrative purposes only and may not be the actual payment applicable to

💸 a purchaser of the notes. The numbers appearing in the following examples have been

rounded for ease of analysis.

Example 1 💸 — Notes are automatically called on the second

Review Date.

Date Closing Price Payment (perR$1,000 principal amount note) First Review

DateR$105.00R$29.50 💸 Second Review DateR$110.00R$1,029.50 Total PaymentR$1,059.00 (5.90%

return)

Because the closing price of one share of the Reference Stock on the second

💸 Review Date is greater than or equal to the Initial Value, the notes will be

automatically called for a cash 💸 payment, for eachR$1,000 principal amount note,

ofR$1,029.50 (orR$1,000 plus the Contingent Interest Payment applicable to the second

Review Date), payable 💸 on the applicable Call Settlement Date. The notes are not

automatically callable before the second Review Date, even though the 💸 closing price of

one share of the Reference Stock on the first Review Date is greater than the Initial

Value. 💸 When added to the Contingent Interest Payment received with respect to the prior

Review Date, the total amount paid, for 💸 eachR$1,000 principal amount note,

isR$1,059.00. No further payments will be made on the notes.

PS- 3 | Structured

Investments Auto Callable 💸 Contingent Interest Notes Linked to the Common Stock of

Biogen Inc.

Example 2 — Notes have NOT been automatically called, the 💸 Final Value is

greater than or equal to the Initial Value and a Trigger Event has occurred.

Date

Closing Price Payment 💸 (perR$1,000 principal amount note) First Review

DateR$95.00R$29.50 Second Review DateR$85.00R$29.50 Third through Fourth Review Dates

Less than Interest BarrierR$0 Final 💸 Review DateR$105.00R$1,029.50 Total

PaymentR$1,088.50 (8.85% return)

Because the notes have not been automatically called

and the Final Value is greater than 💸 or equal to the Initial Value (and, therefore, the

Interest Barrier), even though a Trigger Event has occurred, the payment 💸 at maturity,

for eachR$1,000 principal amount note, will beR$1,029.50 (orR$1,000 plus the Contingent

Interest Payment applicable to the final Review 💸 Date). When added to the Contingent

Interest Payments received with respect to the prior Review Dates, the total amount

paid, 💸 for eachR$1,000 principal amount note, isR$1,088.50.

Example 3 — Notes have NOT

been automatically called, the Final Value is less than 💸 the Initial Value and a Trigger

Event has NOT occurred.

Date Closing Price Payment (perR$1,000 principal amount note)

First Review DateR$95.00R$29.50 💸 Second Review DateR$95.00R$29.50 Third through Fourth

Review Dates Greater than Interest BarrierR$29.50 Final Review DateR$55.00R$1,029.50

Total PaymentR$1,147.50 (14.75% return)

Because the 💸 notes have not been automatically

called, the Final Value is greater than or equal to the Interest Barrier and a 💸 Trigger

Event has not occurred, even though the Final Value is less than the Initial Value, the

payment at maturity, 💸 for eachR$1,000 principal amount note, will beR$1,029.50

(orR$1,000 plus the Contingent Interest Payment applicable to the final Review Date).

When 💸 added to the Contingent Interest Payments received with respect to the prior

Review Dates, the total amount paid, for eachR$1,000 💸 principal amount note,

isR$1,147.50.

Example 4 — Notes have NOT been automatically called, the Final Value is

less than the Initial 💸 Value and the Interest Barrier and a Trigger Event has

occurred.

Date Closing Price Payment (perR$1,000 principal amount note) First Review

💸 DateR$40.00R$0 Second Review DateR$45.00R$0 Third through Fourth Review Dates Less than

Interest BarrierR$0 Final Review DateR$45.00R$450.00 Total PaymentR$450.00 (-55.00%

return)

Because 💸 the notes have not been automatically called, the Final Value of the

Reference Stock is less than the Initial Value 💸 and the Interest Barrier, a Trigger

Event has occurred and the Stock Return is -55.00%, the payment at maturity will

💸 beR$450.00 perR$1,000 principal amount note, calculated as follows:

$1,000 + [$1,000 ×

(-55.00%)] =R$450.00

The hypothetical returns and hypothetical payments on the 💸 notes

shown above apply only if you hold the notes for their entire term or until

automatically called. These hypotheticals 💸 do not reflect the fees or expenses that

would be associated with any sale in the secondary market. If these 💸 fees and expenses

were included, the hypothetical returns and hypothetical payments shown above would

likely be lower.

PS- 4 | Structured 💸 Investments Auto Callable Contingent Interest Notes

Linked to the Common Stock of Biogen Inc.

Selected Risk Considerations

An investment in

the notes 💸 involves significant risks. These risks are explained in more detail in the

“Risk Factors” section of the accompanying product supplement.

● 💸 YOUR INVESTMENT IN THE

NOTES MAY RESULT IN A LOSS —

The notes do not guarantee any return of principal. If 💸 the

notes have not been automatically called and (i) the Final Value is less than the

Initial Value and (ii) 💸 a Trigger Event has occurred, you will lose 1% of the principal

amount of your notes for every 1% that 💸 the Final Value is less than the Initial Value.

Accordingly, under these circumstances, you will lose some or all of 💸 your principal

amount at maturity.

● THE NOTES DO NOT GUARANTEE THE PAYMENT OF INTEREST AND MAY NOT

PAY ANY INTEREST 💸 AT ALL —

If the notes have not been automatically called, we will make

a Contingent Interest Payment with respect to 💸 a Review Date only if the closing price

of one share of the Reference Stock on that Review Date is 💸 greater than or equal to the

Interest Barrier. If the closing price of one share of the Reference Stock on 💸 that

Review Date is less than the Interest Barrier, no Contingent Interest Payment will be

made with respect to that 💸 Review Date. Accordingly, if the closing price of one share

of the Reference Stock on each Review Date is less 💸 than the Interest Barrier, you will

not receive any interest payments over the term of the notes.

● CREDIT RISKS OF

💸 JPMORGAN FINANCIAL AND JPMORGAN CHASE & CO. —

Investors are dependent on our and

JPMorgan Chase & Co.’s ability to pay 💸 all amounts due on the notes. Any actual or

potential change in our or JPMorgan Chase & Co.’s creditworthiness or 💸 credit spreads,

as determined by the market for taking that credit risk, is likely to adversely affect

the value of 💸 the notes. If we and JPMorgan Chase & Co. were to default on our payment

obligations, you may not receive 💸 any amounts owed to you under the notes and you could

lose your entire investment.

● AS A FINANCE SUBSIDIARY, JPMORGAN 💸 FINANCIAL HAS NO

INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS —

As a finance subsidiary of JPMorgan

Chase & Co., we have 💸 no independent operations beyond the issuance and administration

of our securities. Aside from the initial capital contribution from JPMorgan Chase 💸 &

Co., substantially all of our assets relate to obligations of our affiliates to make

payments under loans made by 💸 us or other intercompany agreements. As a result, we are

dependent upon payments from our affiliates to meet our obligations 💸 under the notes. If

these affiliates do not make payments to us and we fail to make payments on the 💸 notes,

you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and

that guarantee will 💸 rank pari passu with all other unsecured and unsubordinated

obligations of JPMorgan Chase & Co.

● THE APPRECIATION POTENTIAL OF THE 💸 NOTES IS

LIMITED TO THE SUM OF ANY CONTINGENT INTEREST PAYMENTS THAT MAY BE PAID OVER THE TERM

OF THE 💸 NOTES,

regardless of any appreciation of the Reference Stock, which may be

significant. You will not participate in any appreciation of 💸 the Reference Stock.

POTENTIAL CONFLICTS —

We and our affiliates play a variety of roles in connection with

the notes. In 💸 performing these duties, our and JPMorgan Chase & Co.’s economic

interests are potentially adverse to your interests as an investor 💸 in the notes. It is

possible that hedging or trading activities of ours or our affiliates in connection

with the 💸 notes could result in substantial returns for us or our affiliates while the

value of the notes declines. Please refer 💸 to “Risk Factors — Risks Relating to

Conflicts of Interest” in the accompanying product supplement.

● THE BENEFIT PROVIDED

BY THE 💸 TRIGGER VALUE MAY TERMINATE ON ANY DAY DURING THE MONITORING PERIOD—

If, on any

day during the Monitoring Period, the closing 💸 price of one share of the Reference Stock

is less than the Trigger Value (i.e., a Trigger Event occurs) and 💸 the notes have not

been automatically called, the benefit provided by the Trigger Value will terminate and

you will be 💸 fully exposed to any depreciation of the Reference Stock. You will be

subject to this potential loss of principal even 💸 if the Reference Stock subsequently

recovers such that the closing price of one share of the Reference Stock is greater

💸 than or equal to the Trigger Value.

● THE AUTOMATIC CALL FEATURE MAY FORCE A POTENTIAL

EARLY EXIT —

If your notes 💸 are automatically called, the term of the notes may be

reduced to as short as approximately six months and you 💸 will not receive any Contingent

Interest Payments after the applicable Call Settlement Date. There is no guarantee that

you would 💸 be able to reinvest the proceeds from an investment in the notes at a

comparable return and/or with a comparable 💸 interest rate for a similar level of risk.

Even in cases where the notes are called before maturity, you are 💸 not entitled to any

fees and commissions described on the front cover of this pricing supplement.

● YOU

WILL NOT RECEIVE 💸 DIVIDENDS ON THE REFERENCE STOCK OR HAVE ANY RIGHTS WITH RESPECT TO

THE REFERENCE STOCK.

● NO AFFILIATION WITH THE REFERENCE 💸 STOCK ISSUER —

We have not

independently verified any of the information about the Reference Stock issuer

contained in this pricing 💸 supplement. You should undertake your own investigation into

the Reference Stock and its issuer. We are not responsible for the 💸 Reference Stock

issuer’s public disclosure of information, whether contained in SEC filings or

otherwise.

● THE ANTI-DILUTION PROTECTION FOR THE REFERENCE 💸 STOCK IS LIMITED AND MAY BE

DISCRETIONARY —

The calculation agent will not make an adjustment in response to all

events 💸 that could affect the Reference Stock. The calculation agent may make

adjustments in response to events that are not described 💸 in the accompanying product

supplement to account for any diluting or concentrative effect, but the calculation

agent is under no 💸 obligation to do so or to consider your interests as a holder of the

notes in making these determinations.

PS- 5 💸 | Structured Investments Auto Callable

Contingent Interest Notes Linked to the Common Stock of Biogen Inc.

● THE RISK OF THE

💸 CLOSING PRICE OF THE REFERENCE STOCK FALLING BELOW THE INTEREST BARRIER OR THE TRIGGER

VALUE IS GREATER IF THE PRICE 💸 OF THE REFERENCE STOCK IS VOLATILE.

● LACK OF

LIQUIDITY—

The notes will not be listed on any securities exchange. Accordingly, the

💸 price at which you may be able to trade your notes is likely to depend on the price, if

any, 💸 at which JPMS is willing to buy the notes. You may not be able to sell your notes.

The notes 💸 are not designed to be short-term trading instruments. Accordingly, you

should be able and willing to hold your notes to 💸 maturity.

● THE ESTIMATED VALUE OF THE

NOTES IS LOWER THAN THE ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES 💸 —

The

estimated value of the notes is only an estimate determined by reference to several

factors. The original issue price 💸 of the notes exceeds the estimated value of the notes

because costs associated with selling, structuring and hedging the notes 💸 are included

in the original issue price of the notes. These costs include the selling commissions,

the projected profits, if 💸 any, that our affiliates expect to realize for assuming risks

inherent in hedging our obligations under the notes and the 💸 estimated cost of hedging

our obligations under the notes. See “The Estimated Value of the Notes” in this pricing

supplement.

● 💸 THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE VALUES OF THE

NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES 💸 —

See “The Estimated Value of the Notes” in

this pricing supplement.

● THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY 💸 REFERENCE TO

AN INTERNAL FUNDING RATE —

The internal funding rate used in the determination of the

estimated value of the 💸 notes may differ from the market-implied funding rate for

vanilla fixed income instruments of a similar maturity issued by JPMorgan 💸 Chase & Co.

or its affiliates. Any difference may be based on, among other things, our and our

affiliates’ view 💸 of the funding value of the notes as well as the higher issuance,

operational and ongoing liability management costs of 💸 the notes in comparison to those

costs for the conventional fixed income instruments of JPMorgan Chase & Co. This

internal 💸 funding rate is based on certain market inputs and assumptions, which may

prove to be incorrect, and is intended to 💸 approximate the prevailing market replacement

funding rate for the notes. The use of an internal funding rate and any potential

💸 changes to that rate may have an adverse effect on the terms of the notes and any

secondary market prices 💸 of the notes. See “The Estimated Value of the Notes” in this

pricing supplement.

● THE VALUE OF THE NOTES AS 💸 PUBLISHED BY JPMS (AND WHICH MAY BE

REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE THEN-CURRENT ESTIMATED

VALUE 💸 OF THE NOTES FOR A LIMITED TIME PERIOD —

We generally expect that some of the

costs included in the original 💸 issue price of the notes will be partially paid back to

you in connection with any repurchases of your notes 💸 by JPMS in an amount that will

decline to zero over an initial predetermined period. See “Secondary Market Prices of

💸 the Notes” in this pricing supplement for additional information relating to this

initial period. Accordingly, the estimated value of your 💸 notes during this initial

period may be lower than the value of the notes as published by JPMS (and which 💸 may be

shown on your customer account statements).

● SECONDARY MARKET PRICES OF THE NOTES WILL

LIKELY BE LOWER THAN THE 💸 ORIGINAL ISSUE PRICE OF THE NOTES —

Any secondary market

prices of the notes will likely be lower than the original 💸 issue price of the notes

because, among other things, secondary market prices take into account our internal

secondary market funding 💸 rates for structured debt issuances and, also, because

secondary market prices may exclude selling commissions, projected hedging profits, if

any, 💸 and estimated hedging costs that are included in the original issue price of the

notes. As a result, the price, 💸 if any, at which JPMS will be willing to buy the notes

from you in secondary market transactions, if at 💸 all, is likely to be lower than the

original issue price. Any sale by you prior to the Maturity Date 💸 could result in a

substantial loss to you.

● SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY

MANY ECONOMIC 💸 AND MARKET FACTORS —

The secondary market price of the notes during their

term will be impacted by a number of 💸 economic and market factors, which may either

offset or magnify each other, aside from the selling commissions, projected hedging

profits, 💸 if any, estimated hedging costs and the price of the Reference Stock.

Additionally, independent pricing vendors and/or third party broker-dealers 💸 may publish

a price for the notes, which may also be reflected on customer account statements. This

price may be 💸 different (higher or lower) than the price of the notes, if any, at which

JPMS may be willing to purchase 💸 your notes in the secondary market. See “Risk Factors —

Risks Relating to the Estimated Value and Secondary Market Prices 💸 of the Notes —

Secondary market prices of the notes will be impacted by many economic and market

factors” in 💸 the accompanying product supplement.

The Reference Stock

All information

contained herein on the Reference Stock and on Biogen is derived from publicly

💸 available sources, without independent verification. According to its publicly

available filings with the SEC, Biogen is a biotechnology company focused 💸 on

discovering, developing, manufacturing and marketing therapies for treatment of

multiple sclerosis and other autoimmune disorders, neurodegenerative diseases and

hemophilia. 💸 The common stock of Biogen, par valueR$0.0005 per share (Bloomberg ticker:

BIIB) is registered under the Securities Exchange Act of 💸 1934, as amended, which we

refer to as the Exchange Act, and is listed on The NASDAQ Stock Market, which 💸 we refer

to as the relevant exchange for purposes of Biogen in the accompanying product

supplement. Information provided to or 💸 filed with the SEC by Biogen pursuant to the

Exchange Act can be located by reference to SEC file number 💸 000-19311, and can be

accessed through sec. We do not make any representation that these publicly available

documents are accurate 💸 or complete.

PS- 6 | Structured Investments Auto Callable

Contingent Interest Notes Linked to the Common Stock of Biogen Inc.

Historical

Information

The 💸 following graph sets forth the historical performance of the Reference

Stock based on the weekly historical closing prices of one 💸 share of the Reference Stock

from January 2, 2024 through January 31, 2024. The closing price of one share of 💸 the

Reference Stock on January 31, 2024 wasR$268.85. We obtained the closing prices above

and below from the Bloomberg Professional® 💸 service (“Bloomberg”), without independent

verification. The closing prices above and below may have been adjusted by Bloomberg

for corporate actions, 💸 such as stock splits, public offerings, mergers and

acquisitions, spin-offs, delistings and bankruptcy.

The historical closing prices of

one share of 💸 the Reference Stock should not be taken as an indication of future

performance, and no assurance can be given as 💸 to the closing price of one share of the

Reference Stock on any Review Date or any day during the 💸 Monitoring Period. There can

be no assurance that the performance of the Reference Stock will result in the return

of 💸 any of your principal amount or the payment of any interest.

Historical Performance

of Biogen Inc. Source: Bloomberg

Tax Treatment

You should review 💸 carefully the section

entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product

supplement no. 4-I. In determining our 💸 reporting responsibilities we intend to treat

(i) the notes for U.S. federal income tax purposes as prepaid forward contracts with

💸 associated contingent coupons and (ii) any Contingent Interest Payments as ordinary

income, as described in the section entitled “Material U.S. 💸 Federal Income Tax

Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward

Contracts with Associated Contingent 💸 Coupons” in the accompanying product supplement.

Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel, 💸 we believe

that this is a reasonable treatment, but that there are other reasonable treatments

that the IRS or a 💸 court may adopt, in which case the timing and character of any income

or loss on the notes could be 💸 materially affected. In addition, in 2007 Treasury and

the IRS released a notice requesting comments on the U.S. federal income 💸 tax treatment

of “prepaid forward contracts” and similar instruments. The notice focuses in

particular on whether to require investors in 💸 these instruments to accrue income over

the term of their investment. It also asks for comments on a number of 💸 related topics,

including the character of income or loss with respect to these instruments and the

relevance of factors such 💸 as the nature of the underlying property to which the

instruments are linked. While the notice requests comments on appropriate 💸 transition

rules and effective dates, any Treasury regulations or other guidance promulgated after

consideration of these issues could materially affect 💸 the tax consequences of an

investment in the notes, possibly with retroactive effect. The discussions above and in

the accompanying 💸 product supplement do not address the consequences to taxpayers

subject to special tax accounting rules under Section 451(b) of the 💸 Code. You should

consult your tax adviser regarding the U.S. federal income tax consequences of an

investment in the notes, 💸 including possible alternative treatments and the issues

presented by the notice described above.

Non-U.S. Holders — Tax Considerations. The

U.S. federal 💸 income tax treatment of Contingent Interest Payments is uncertain, and

although we believe it is reasonable to take a position 💸 that Contingent Interest

Payments are not subject to U.S. withholding tax (at least if an applicable Form W-8 is

provided), 💸 a withholding agent may nonetheless withhold on these payments (generally at

a rate of 30%, subject to the possible reduction 💸 of that rate under an applicable

income tax treaty), unless income from your notes is effectively connected with your

conduct 💸 of a trade or business in the United States (and, if an applicable treaty so

requires, attributable to a permanent 💸 establishment in the United States). If you are

not a United States person, you are urged to consult your tax 💸 adviser regarding the

U.S. federal income tax consequences of an investment in the notes in light of your

particular circumstances.

PS- 💸 7 | Structured Investments Auto Callable Contingent

Interest Notes Linked to the Common Stock of Biogen Inc.

Section 871(m) of the 💸 Code and

Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30%

withholding tax (unless an income tax treaty applies) 💸 on dividend equivalents paid or

deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to

U.S. equities 💸 or indices that include U.S. equities. Section 871(m) provides certain

exceptions to this withholding regime, including for instruments linked to 💸 certain

broad-based indices that meet requirements set forth in the applicable Treasury

regulations (such an index, a “Qualified Index”). Additionally, 💸 a recent IRS notice

excludes from the scope of Section 871(m) instruments issued prior to January 1, 2024

that do 💸 not have a delta of one with respect to underlying securities that could pay

U.S.-source dividends for U.S. federal income 💸 tax purposes (each an “Underlying

Security”). Based on certain determinations made by us, our special tax counsel is of

the 💸 opinion that Section 871(m) should not apply to the notes with regard to Non-U.S.

Holders. Our determination is not binding 💸 on the IRS, and the IRS may disagree with

this determination. Section 871(m) is complex and its application may depend 💸 on your

particular circumstances, including whether you enter into other transactions with

respect to an Underlying Security. You should consult 💸 your tax adviser regarding the

potential application of Section 871(m) to the notes.

FATCA. Withholding under

legislation commonly referred to as 💸 “FATCA” could apply to payments with respect to the

notes that are treated as U.S.-source “fixed or determinable annual or 💸 periodical”

income (“FDAP Income”) for U.S. federal income tax purposes (such as interest, if the

notes are recharacterized, in whole 💸 or in part, as debt instruments, or Contingent

Interest Payments if they are otherwise treated as FDAP Income). If the 💸 notes are

recharacterized, in whole or in part, as debt instruments, withholding could also apply

to payments of gross proceeds 💸 of a taxable disposition, including an early redemption

or redemption at maturity, although under recently proposed regulations (the preamble

to 💸 which specifies that taxpayers are permitted to rely on them pending finalization),

no withholding will apply to payments of gross 💸 proceeds (other than any amount treated

as FDAP Income). You should consult your tax adviser regarding the potential

application of 💸 FATCA to the notes.

In the event of any withholding on the notes, we

will not be required to pay any 💸 additional amounts with respect to amounts so

withheld.

The Estimated Value of the Notes

The estimated value of the notes set forth

💸 on the cover of this pricing supplement is equal to the sum of the values of the

following hypothetical components: 💸 (1) a fixed-income debt component with the same

maturity as the notes, valued using the internal funding rate described below, 💸 and (2)

the derivative or derivatives underlying the economic terms of the notes. The estimated

value of the notes does 💸 not represent a minimum price at which JPMS would be willing to

buy your notes in any secondary market (if 💸 any exists) at any time. The internal

funding rate used in the determination of the estimated value of the notes 💸 may differ

from the market-implied funding rate for vanilla fixed income instruments of a similar

maturity issued by JPMorgan Chase 💸 & Co. or its affiliates. Any difference may be based

on, among other things, our and our affiliates’ view of 💸 the funding value of the notes

as well as the higher issuance, operational and ongoing liability management costs of

the 💸 notes in comparison to those costs for the conventional fixed income instruments of

JPMorgan Chase & Co. This internal funding 💸 rate is based on certain market inputs and

assumptions, which may prove to be incorrect, and is intended to approximate 💸 the

prevailing market replacement funding rate for the notes. The use of an internal

funding rate and any potential changes 💸 to that rate may have an adverse effect on the

terms of the notes and any secondary market prices of 💸 the notes. For additional

information, see “Selected Risk Considerations — The Estimated Value of the Notes Is

Derived by Reference 💸 to an Internal Funding Rate” in this pricing supplement.

The value

of the derivative or derivatives underlying the economic terms of 💸 the notes is derived

from internal pricing models of our affiliates. These models are dependent on inputs

such as the 💸 traded market prices of comparable derivative instruments and on various

other inputs, some of which are market-observable, and which can 💸 include volatility,

dividend rates, interest rates and other factors, as well as assumptions about future

market events and/or environments. Accordingly, 💸 the estimated value of the notes is

determined when the terms of the notes are set based on market conditions 💸 and other

relevant factors and assumptions existing at that time.

The estimated value of the

notes does not represent future values 💸 of the notes and may differ from others’

estimates. Different pricing models and assumptions could provide valuations for the

notes 💸 that are greater than or less than the estimated value of the notes. In addition,

market conditions and other relevant 💸 factors in the future may change, and any

assumptions may prove to be incorrect. On future dates, the value of 💸 the notes could

change significantly based on, among other things, changes in market conditions, our or

JPMorgan Chase & Co.’s 💸 creditworthiness, interest rate movements and other relevant

factors, which may impact the price, if any, at which JPMS would be 💸 willing to buy

notes from you in secondary market transactions.

The estimated value of the notes is

lower than the original 💸 issue price of the notes because costs associated with selling,

structuring and hedging the notes are included in the original 💸 issue price of the

notes. These costs include the selling commissions paid to JPMS and other affiliated or

unaffiliated dealers, 💸 the projected profits, if any, that our affiliates expect to

realize for assuming risks inherent in hedging our obligations under 💸 the notes and the

estimated cost of hedging our obligations under the notes. Because hedging our

obligations entails risk and 💸 may be influenced by market forces beyond our control,

this hedging may result in a profit that is more or 💸 less than expected, or it may

result in a loss. A portion of the profits, if any, realized in hedging 💸 our obligations

under the notes may be allowed to other affiliated or unaffiliated dealers, and we or

one or more 💸 of our affiliates will retain any remaining hedging profits. See “Selected

Risk Considerations — The Estimated Value of the Notes 💸 Is Lower Than the Original Issue

Price (Price to Public) of the Notes” in this pricing supplement.

PS- 8 | Structured

💸 Investments Auto Callable Contingent Interest Notes Linked to the Common Stock of

Biogen Inc.

Secondary Market Prices of the Notes

For information 💸 about factors that

will impact any secondary market prices of the notes, see “Risk Factors — Risks

Relating to the 💸 Estimated Value and Secondary Market Prices of the Notes — Secondary

market prices of the notes will be impacted by 💸 many economic and market factors” in the

accompanying product supplement. In addition, we generally expect that some of the

costs 💸 included in the original issue price of the notes will be partially paid back to

you in connection with any 💸 repurchases of your notes by JPMS in an amount that will

decline to zero over an initial predetermined period. These 💸 costs can include selling

commissions, projected hedging profits, if any, and, in some circumstances, estimated

hedging costs and our internal 💸 secondary market funding rates for structured debt

issuances. This initial predetermined time period is intended to be the shorter of 💸 six

months and one-half of the stated term of the notes. The length of any such initial

period reflects the 💸 structure of the notes, whether our affiliates expect to earn a

profit in connection with our hedging activities, the estimated 💸 costs of hedging the

notes and when these costs are incurred, as determined by our affiliates. See “Selected

Risk Considerations 💸 — The Value of the Notes as Published by JPMS (and Which May Be

Reflected on Customer Account Statements) May 💸 Be Higher Than the Then-Current Estimated

Value of the Notes for a Limited Time Period” in this pricing supplement.

Supplemental

Use 💸 of Proceeds

The notes are offered to meet investor demand for products that reflect

the risk-return profile and market exposure provided 💸 by the notes. See “How the Notes

Work” and “Hypothetical Payout Examples” in this pricing supplement for an illustration

of 💸 the risk-return profile of the notes and “The Reference Stock” in this pricing

supplement for a description of the market 💸 exposure provided by the notes.

The original

issue price of the notes is equal to the estimated value of the notes 💸 plus the selling

commissions paid to JPMS and other affiliated or unaffiliated dealers, plus (minus) the

projected profits (losses) that 💸 our affiliates expect to realize for assuming risks

inherent in hedging our obligations under the notes, plus the estimated cost 💸 of hedging

our obligations under the notes.

Supplemental Plan of Distribution

We expect that

delivery of the notes will be made against 💸 payment for the notes on or about the

Original Issue Date set forth on the front cover of this pricing 💸 supplement, which will

be the third business day following the Pricing Date of the notes (this settlement

cycle being referred 💸 to as “T+3”). Under Rule 15c6-1 of the Securities Exchange Act of

1934, as amended, trades in the secondary market 💸 generally are required to settle in

two business days, unless the parties to that trade expressly agree otherwise.

Accordingly, purchasers 💸 who wish to trade notes on any date prior to two business days

before delivery will be required to specify 💸 an alternate settlement cycle at the time

of any such trade to prevent a failed settlement and should consult their 💸 own

advisors.

Validity of the Notes and the Guarantee

In the opinion of Davis Polk &

Wardwell LLP, as special products counsel 💸 to JPMorgan Financial and JPMorgan Chase &

Co., when the notes offered by this pricing supplement have been executed and 💸 issued by

JPMorgan Financial and authenticated by the trustee pursuant to the indenture, and

delivered against payment as contemplated herein, 💸 such notes will be valid and binding

obligations of JPMorgan Financial and the related guarantee will constitute a valid and

💸 binding obligation of JPMorgan Chase & Co., enforceable in accordance with their terms,

subject to applicable bankruptcy, insolvency and similar 💸 laws affecting creditors’

rights generally, concepts of reasonableness and equitable principles of general

applicability (including, without limitation, concepts of good 💸 faith, fair dealing and

the lack of bad faith), provided that such counsel expresses no opinion as to (i) the

💸 effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable

law on the conclusions expressed above or (ii) any 💸 provision of the indenture that

purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar

provision of applicable 💸 law by limiting the amount of JPMorgan Chase & Co.’s obligation

under the related guarantee. This opinion is given as 💸 of the date hereof and is limited

to the laws of the State of New York, the General Corporation Law 💸 of the State of

Delaware and the Delaware Limited Liability Company Act. In addition, this opinion is

subject to customary 💸 assumptions about the trustee’s authorization, execution and

delivery of the indenture and its authentication of the notes and the validity, 💸 binding

nature and enforceability of the indenture with respect to the trustee, all as stated

in the letter of such 💸 counsel dated March 8, 2024, which was filed as an exhibit to the

Registration Statement on Form S-3 by JPMorgan 💸 Financial and JPMorgan Chase & Co. on

March 8, 2024.

PS- 9 | Structured Investments Auto Callable Contingent Interest Notes

Linked 💸 to the Common Stock of Biogen Inc.

Additional Terms Specific to the Notes

You

should read this pricing supplement together with the 💸 accompanying prospectus, as

supplemented by the accompanying prospectus supplement relating to our Series A

medium-term notes of which these notes 💸 are a part, and the more detailed information

contained in the accompanying product supplement. This pricing supplement, together

with the 💸 documents listed below, contains the terms of the notes and supersedes all

other prior or contemporaneous oral statements as well 💸 as any other written materials

including preliminary or indicative pricing terms, correspondence, trade ideas,

structures for implementation, sample structures, fact 💸 sheets, brochures or other

educational materials of ours. You should carefully consider, among other things, the

matters set forth in 💸 the “Risk Factors” section of the accompanying product supplement,

as the notes involve risks not associated with conventional debt securities. 💸 We urge

you to consult your investment, legal, tax, accounting and other advisers before you

invest in the notes.

You may 💸 access these documents on the SEC website at sec as

follows (or if such address has changed, by reviewing our 💸 filings for the relevant date

on the SEC website):

● Product supplement no. 4-I dated April 5,

2024:

http://sec/Archives/edgar/data/19617/000095010318004519/dp87528_424b2-ps4i.pdf

Prospectus supplement and 💸 prospectus, each dated April 5,

2024:

http://sec/Archives/edgar/data/19617/000095010318004508/dp87767_424b2-ps.pdf

Our

Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase 💸 & Co.’s

CIK is 19617. As used in this pricing supplement, “we,” “us” and “our” refer to

JPMorgan Financial.

I refer to all the days as "Bonus Days." Now that I am in my golden years I refer to them as "Double Bonus Days!"